European Study of Dronedarone in Atrial Fibrillation
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of dronedarone for the control of
ventricular rate at rest and during exercise in patients with atrial fibrillation (AF) and to
assess the tolerability of dronedarone in the target population.